INTENT TO SOLE SOURCE AEMS Think Trends Licenses (Brand Name)

Description: The Food and Drug Administration requires Think Trends Software Licenses to reduce manual case-processing burdens, improve extraction accuracy, accelerate regulatory review workflows, and support adverse-event reporting. The software will provide configurable AI agents, human-in-the-loop validation, auditability, and secure deployment within FDA-approved environments. The FDA intends a sole-source, one-year acquisition because the proposed source has unique technical resources, with performance in Silver Spring, Maryland.